Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/172131
Title: Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenstrom macroglobulinemia
Author: McMaster, Mary L.
Berndt, Sonja I.
Zhang, Jianping
Slager, Susan L.
Li, Shengchao Alfred
Vajdic, Claire M.
Smedby, Karin E.
Yan, Huihuang
Birmann, Brenda M.
Brown, Elizabeth E.
Smith, Alex
Kleinstern, Geffen
Fansler, Mervin M.
Mayr, Christine
Zhu, Bin
Chung, Charles C.
Park, Ju-Hyun
Burdette, Laurie
Hicks, Belynda D.
Hutchinson, Amy
Teras, Lauren R.
Adami, Hans-Olov
Bracci, Paige M.
McKay, James D.
Monnereau, Alain
Link, Brian K.
Vermeulen, Roel C. H.
Ansell, Stephen M.
Maria, Ann
Diver, W. Ryan
Melbye, Mads
Ojesina, Akinyemi I.
Kraft, Peter
Boffetta, Paolo
Clavel, Jacqueline
Giovannucci, Edward
Besson, Caroline
Canzian, Federico
Travis, Ruth C.
Vineis, Paolo
Weiderpass, Elisabete
Montalvan, Rebecca
Wang, Zhaoming
Yeager, Meredith
Becker, Nikolaus
Benavente, Yolanda
Brennan, Paul
Foretova, Lenka
Maynadié, Marc
Nieters, Alexandra
Sanjosé Llongueras, Silvia de
Staines, Anthony
Conde, Lucía
Riby, Jacques
Glimelius, Bengt
Hjalgrim, Henrik
Pradhan, Nisha
Feldman, Andrew L.
Novak, Anne J.
Lawrence, Charles
Bassig, Bryan A.
Lan, Qing
Zheng, Tongzhang
North, Kari E.
Tinker, Lesley F.
Cozen, Wendy
Severson, Richard K.
Hofmann, Jonathan N.
Zhang, Yawei
Jackson, Rebecca D.
Morton, Lindsay M.
Purdue, Mark P.
Chatterjee, Nilanjan
Offit, Kenneth
Cerhan, James R.
Chanock, Stephen J.
Rothman, Nathaniel
Vijai, Joseph
Goldin, Lynn R.
Skibola, Christine F.
Caporaso, Neil E.
Keywords: Malalties del sistema limfàtic
Leucèmia
Lymphatic diseases
Leukemia
Issue Date: 10-Oct-2018
Publisher: Nature Publishing Group
Abstract: Waldenstrom macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is a rare, chronic B-cell lymphoma with high heritability. We conduct a two-stage genome-wide association study of WM/LPL in 530 unrelated cases and 4362 controls of European ancestry and identify two high-risk loci associated with WM/LPL at 6p25.3 (rs116446171, near EXOC2 and IRF4; OR = 21.14, 95% CI: 14.40-31.03, P=1.36 x 10(-)(54)) and 14q32.13 (rs117410836, near TCL1; OR = 4.90, 95% CI: 3.45-6.96, P = 8.75 x 10(-)(19)) . Both risk alleles are observed at a low frequency among controls (similar to 2-3%) and occur in excess in affected cases within families. In silico data suggest that rs116446171 may have functional importance, and in functional studies, we demonstrate increased reporter transcription and proliferation in cells transduced with the 6p25.3 risk allele. Although further studies are needed to fully elucidate underlying biological mechanisms, together these loci explain 4% of the familial risk and provide insights into genetic susceptibility to this malignancy.
Note: Reproducció del document publicat a: https://doi.org/10.1038/s41467-018-06541-2
It is part of: Nature Communications, 2018, vol. 9
URI: http://hdl.handle.net/2445/172131
Related resource: https://doi.org/10.1038/s41467-018-06541-2
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
McMasterML.pdf1.38 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons